NYC Startups Raise $28.5M: Daptic Leads With $15M Series A

New York City startups raised at least $28.5M across three disclosed deals on October 1, 2026, with AI-driven compliance platform Daptic accounting for $15M of the total, according to AlleyWatch's daily funding report.

The day's activity spanned enterprise software, clinical diagnostics, and robotics — three sectors where NYC founders continue to attract institutional capital at every stage, from pre-seed to Series A.

What did Daptic raise?

Daptic, a product compliance software platform that helps manufacturers build regulatory requirements into product design and development, closed a $15M Series A led by Canvas Ventures. IA Ventures and 8VC also participated.

The company has now raised $22M in reported equity funding in total. Baptiste Bouvier, Hannah Collins, and Gabby Finear founded Daptic in 2023.

The round signals investor appetite for tools that bake regulation into the engineering workflow rather than treating compliance as an afterthought. For manufacturers, redesigning products late in development to meet regulatory demands is costly. Daptic positions its software as a way to avoid that outcome from day one.

Why did Biotia secure $9M?

Biotia, a clinical diagnostics company, raised $9M in venture funding — the day's second-largest round. The company uses metagenomic sequencing to identify the cause of recurrent and complicated urinary tract infections.

The investor syndicate is notably broad. It includes:

• Convergent Ventures
• DigitalDx Ventures
• Cloquet Capital Partners
• Continuum Health Ventures
• I-Lab Angels
• EGB Capital
• Leawood Venture Capital
• Red Bear Angels
• Red Bear Ventures
• Individual investors Tim Barry and Clive Fields

Niamh O'Hara, Chris Mason, and Rachid Ounit founded Biotia in 2016. The company has now raised $19.4M in reported equity funding.

A decade of work on sequencing-based diagnostics is now drawing a wider checkbook. The breadth of the syndicate — spanning health-focused funds, angel groups, and family offices — suggests Biotia is financing commercialization rather than early research.

What is Tangent Robotics building?

Tangent Robotics raised $4.5M in pre-seed funding, the earliest-stage deal of the day. The round was led by Fly Ventures and Toyota Ventures, with Logos Fund and Sparked Ventures participating.

The company builds touch-sensing robot hands and motor learning software to automate fine, high-precision manufacturing tasks. Pedro Piacenza, Matei Ciocarlie, and Ioannis Kymissis founded Tangent Robotics in 2025.

Toyota Ventures' involvement is the notable signal here. The corporate VC arm of one of the world's largest manufacturers rarely leads pre-seed checks without a strategic rationale. Precision assembly automation sits squarely in the automaker's long-term robotics interest.

Touch sensing remains one of the harder problems in robotics. Vision systems have advanced rapidly; tactile feedback for delicate, high-precision manipulation has lagged. A pre-seed round backed by two lead investors indicates confidence that Tangent's founding team — with academic depth across robotics and engineering — can attack the problem early.

What does the day's tally say?

Three deals, three stages: a Series A, a venture round, and a pre-seed. Total disclosed funding: $28.5M.

The pattern matches where NYC venture capital has been flowing. Compliance software monetizes regulatory complexity that shows no sign of shrinking. Diagnostics companies with sequenced-based platforms continue to raise growth capital. And robotics hardware, historically capital-intensive and risky at the earliest stages, is pulling corporate money into pre-seed rounds.

AlleyWatch notes its report updates throughout the day as new fundings come in, so the $28.5M figure could rise. For founders tracking comparables, the Daptic round — $15M on top of a $7M prior base — sets a fresh Series A benchmark for NYC compliance-tech; for investors, Tangent's dual-lead pre-seed shows corporate strategics moving earlier into tactile robotics.